ACTEMRA
Biological
Genentech USA, Inc.
Total Payments
$12,798
Transactions
6
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $12,798 | 6 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Space rental or facility fees (teaching hospital only) | $12,750 | 3 | 99.6% |
| Food and Beverage | $47.70 | 3 | 0.4% |
Ad
Manufacturing Companies
- Genentech USA, Inc. $12,798
Product Information
- Type Biological
- Total Payments $12,798
- Total Doctors 3
- Transactions 6
About ACTEMRA
ACTEMRA is a biological associated with $12,798 in payments to 3 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is Genentech USA, Inc..
Payment data is available from 2020 to 2020. In 2020, $12,798 was paid across 6 transactions to 3 doctors.
The most common payment nature for ACTEMRA is "Space rental or facility fees (teaching hospital only)" ($12,750, 99.6% of total).